Zheng Yiping, Cai Jianfeng, Ji Qiuhong, Liu Luanmei, Liao Kaijun, Dong Lie, Gao Jie, Huang Yinghui
Department of Respiratory and Critical Care Medicine, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, Fujian, 353006, China.
Department of Clinical Medicine, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, Fujian, 353006, China.
Curr Cancer Drug Targets. 2025;25(3):294-305. doi: 10.2174/0115680096337237240909101904.
Lung cancer remains a major global health threat due to its complex microenvironment, particularly the role of neutrophils, which are crucial for tumor development and immune evasion mechanisms. This study aimed to delve into the impact of lung cancer cell-conditioned media on neutrophil functions and their potential implications for lung cancer progression.
Employing in vitro experimental models, this study has analyzed the effects of lung cancer cell-conditioned media on neutrophil IL-8 and IFN-γ secretion, apoptosis, PD-L1 expression, and T-cell proliferation by using techniques, such as ELISA, flow cytometry, immunofluorescence, and CFSE proliferation assay. The roles of IL-8/PD-L1 in regulating neutrophil functions were further explored using inhibitors for IL-8 and PD-L1.
Lung cancer cell lines were found to secrete higher levels of IL-8 compared to normal lung epithelial cells. The conditioned media from lung cancer cells significantly reduced apoptosis in neutrophils, increased PD-L1 expression, and suppressed T-cell proliferation and IFN-γ secretion. These effects were partially reversed in the presence of IL-8 inhibitors in Tumor Tissue Culture Supernatants (TTCS), while being further enhanced by IL-8. Both apoptosis and PD-L1 expression in neutrophils demonstrated dose-dependency to TTCS. Additionally, CFSE proliferation assay results further confirmed the inhibitory effect of lung cancer cell-conditioned media on T-- cell proliferation.
This study has revealed lung cancer cell-conditioned media to modulate neutrophil functions through regulating factors, such as IL-8, thereby affecting immune regulation and tumor progression in the lung cancer microenvironment.
肺癌因其复杂的微环境,尤其是中性粒细胞的作用,仍然是全球主要的健康威胁,中性粒细胞对肿瘤发展和免疫逃逸机制至关重要。本研究旨在深入探讨肺癌细胞条件培养基对中性粒细胞功能的影响及其对肺癌进展的潜在影响。
本研究采用体外实验模型,通过酶联免疫吸附测定(ELISA)、流式细胞术、免疫荧光和羧基荧光素二乙酸琥珀酰亚胺酯(CFSE)增殖试验等技术,分析肺癌细胞条件培养基对中性粒细胞白细胞介素-8(IL-8)和干扰素-γ(IFN-γ)分泌、凋亡、程序性死亡受体1(PD-L1)表达及T细胞增殖的影响。使用IL-8和PD-L1抑制剂进一步探讨IL-8/PD-L1在调节中性粒细胞功能中的作用。
与正常肺上皮细胞相比,肺癌细胞系分泌的IL-8水平更高。肺癌细胞条件培养基显著降低中性粒细胞凋亡,增加PD-L1表达,抑制T细胞增殖和IFN-γ分泌。在肿瘤组织培养上清液(TTCS)中存在IL-8抑制剂时,这些作用部分逆转,而IL-8进一步增强这些作用。中性粒细胞的凋亡和PD-L1表达均显示出对TTCS的剂量依赖性。此外,CFSE增殖试验结果进一步证实了肺癌细胞条件培养基对T细胞增殖的抑制作用。
本研究揭示肺癌细胞条件培养基通过调节IL-8等因子来调节中性粒细胞功能,从而影响肺癌微环境中的免疫调节和肿瘤进展。